Company

Apontis Pharma AG

Headquarters: Monheim am Rhein, Germany

Employees: 195

CEO: Mr. Karlheinz Gast

show_chart FSX: APPH -3.65% show_chart XETR: APPH

Market Cap

€72.6 Million

EUR as of Jan. 1, 2023

US$77.4 Million

history Market Cap History

Apontis Pharma AG Categories

Germany languages Healthcare languages Drug Manufacturers—Specialty & Generic
Germany Healthcare Germany Drug Manufacturers—Specialty & Generic

Apontis Pharma AG market capitalization over time

Evolution of Apontis Pharma AG market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Apontis Pharma AG

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $87.64 B
Zoetis Inc. $68.38 B
Takeda Pharmaceutical Company Limited $46.57 B
Eisai Co. Ltd $17.23 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Detailed Description

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It supplies products in the field of respiratory diseases, heart failure, and hypertension to the pharmaceutical market. The company is based in Monheim am Rhein, Germany.

Stocks & Indices

Apontis Pharma AG has the following listings and related stock indices.


Stock: FSX: APPH

Stock: XETR: APPH

Details

Headquarters:

Alfred-Nobel-Str. 10

Monheim am Rhein, 40789

Germany

Phone: 49 2173 8955 1540